The abstract is read at the publisher; the summary is JClub's.
Genomic and phenotypic profiling of Pannonibacter sp. CBAS 1226 from a pediatric acute lymphoblastic leukemia bacteremia in Brazil supports a distinct new species, Candidatus Pannonibacter alzirae.
- Why it matters: Human infections by Pannonibacter are rare and mainly involve immunocompromised patients, leaving uncertainty when isolates show atypical identification by standard proteomics libraries.
- What they did: The team combined MALDI-TOF and 16S rRNA sequencing, then used whole-genome analysis with ANI and dDDH plus biochemical, morphological, antimicrobial resistance, and biofilm/physiology testing.
- The result: CBAS 1226 is phylogenetically distinct from P. phragmitetus and other known species (ANI and dDDH below species thresholds), with distinct enzyme and substrate patterns and low MICs for carbapenems/fluoroquinolones.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.